Related Experiment Video
Updated: Oct 6, 2026

In Vitro Assay to Evaluate the Impact of Immunoregulatory Pathways on HIV-specific CD4 T Cell Effector Function
Published on: October 15, 2013
Effect of an interferon inhibitor on the antiproliferative signal of interferon-alpha
A Aszalos1, K C Chadha, I Stadler
1Division of Research and Testing, Food and Drug Administration, Washington, D.C. 20204.
Insights
Researchers identified a non-antibody interferon (IFN) inhibitor in patients with AIDS, cancer, and lupus. This inhibitor blocks the antiproliferative effects of IFN-alpha and modulates its membrane potential activity.
Area of Science:
- Immunology
- Virology
- Oncology
Background:
- Non-antibody inhibitors of interferons (IFN) have been previously identified in patients with specific immune-compromising and autoimmune conditions.
- These inhibitors may play a role in disease pathogenesis by interfering with crucial immune signaling pathways.
Purpose of the Study:
- To investigate the functional activity of a semipurified non-antibody interferon inhibitor (IFI).
- To determine the effect of IFI on the antiproliferative signaling of interferon-alpha (IFN-alpha) in a cellular model.
Main Methods:
- Utilized Daudi cells, a human B lymphoblastoid cell line, to assess IFN-alpha activity.
- Quantified the antiproliferative effects of IFN-alpha in the presence and absence of the semipurified IFI.
- Measured the modulation of IFN-alpha's membrane potential shifting ability by the IFI preparation.
Main Results:
- The semipurified IFI preparation demonstrated the ability to block the antiproliferative signal induced by IFN-alpha in Daudi cells.
- The interferon inhibitor preparation was shown to modulate the membrane potential shifting ability of IFN-alpha.
Conclusions:
- A non-antibody interferon inhibitor found in patients with AIDS, cancer, and lupus interferes with key interferon-alpha functions.
- This inhibitor's capacity to block antiproliferative signals and modulate membrane potential suggests a significant role in immune dysregulation.
Abstract:
We have described a nonantibody type inhibitor of interferons (IFN) in the blood of patients with AIDS, advanced neoplastic disorders, and lupus erythematosus in earlier reports (1,2). In the present study we show that the semipurified inhibitor blocks the antiproliferative signal of IFN-alpha in Daudi cells and the membrane potential shifting ability of IFN-alpha is modulated by the interferon inhibitor preparation (IFI).
More Related Videos
10:00High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes
Published on: March 24, 2015
08:26Development and Validation of an Ultrasensitive Single Molecule Array Digital Enzyme-linked Immunosorbent Assay for Human Interferon-α
Published on: June 14, 2018
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Inhibitors Of Virion Release